# IGC Pharma, Inc.: Form 8-K, filed Sep 9, 2022

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 8-K
- Filed: 2022-09-09
- Accepted by EDGAR: Sep 9, 2022, 20:55 ET
- Period: 2022-09-09
- Accession: 0001185185-22-001082
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518522001082/indiaglob20220909_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518522001082/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518522001082/indiaglob20220909_8k.htm

Filed Sep 9, 2022.
Source: SEC EDGAR, the filing index for accession 0001185185-22-001082. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.